← Back to search

CASSAVA SCIENCES, INC.

SAVA · NASDAQ

Pharmaceutical Preparation Manufacturing

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.

ESG Scores

Overall ESG
5.9
Environmental
6.1
Social
4.9
Governance
2.9

Gender Diversity

CEO GenderMale

Market Data

Price$1.36-0.08 (-5.56%)
Market Cap$115M
P/E Ratio
EPS$—
52W High$4.98
52W Low$1.16
Beta-0.73